Visco Vision Inc. (TPE:6782)
204.50
-3.00 (-1.45%)
Aug 29, 2025, 1:30 PM CST
Visco Vision Revenue
Visco Vision had revenue of 1.08B TWD in the quarter ending June 30, 2025, with 18.89% growth. This brings the company's revenue in the last twelve months to 3.97B, up 29.98% year-over-year. In the year 2024, Visco Vision had annual revenue of 3.67B with 53.13% growth.
Revenue (ttm)
3.97B
Revenue Growth
+29.98%
P/S Ratio
3.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.67B | 1.27B | 53.13% |
Dec 31, 2023 | 2.40B | -379.85M | -13.68% |
Dec 31, 2022 | 2.78B | 813.03M | 41.39% |
Dec 31, 2021 | 1.96B | 438.11M | 28.70% |
Dec 31, 2020 | 1.53B | 54.37M | 3.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Lumosa Therapeutics | 37.25M |
Polaris Group | 87.67M |
Center Laboratories | 1.60B |